Cell Therapy and Tissue Engineering Market, Global Outlook and Forecast 2022-2028
Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules.
This report contains market size and forecasts of Cell Therapy and Tissue Engineering in Global, including the following market information:
Global Cell Therapy and Tissue Engineering Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cell Therapy and Tissue Engineering market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cell Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cell Therapy and Tissue Engineering include Betalin Therapeutics, BioCardia, Inc, BioReliance Corporation, Biosolution Co., Brainstorm Cell Therapeutics, Inc, MaxCyte, Inc, Medigene AG, MEDIPOST CO. and Mesoblast Limited, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cell Therapy and Tissue Engineering companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell Therapy and Tissue Engineering Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cell Therapy and Tissue Engineering Market Segment Percentages, by Type, 2021 (%)
Global Cell Therapy and Tissue Engineering Market Segment Percentages, by Application, 2021 (%)
Global Cell Therapy and Tissue Engineering Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Cell Therapy and Tissue Engineering revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cell Therapy and Tissue Engineering revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Cell Therapy and Tissue Engineering in Global, including the following market information:
Global Cell Therapy and Tissue Engineering Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cell Therapy and Tissue Engineering market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cell Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cell Therapy and Tissue Engineering include Betalin Therapeutics, BioCardia, Inc, BioReliance Corporation, Biosolution Co., Brainstorm Cell Therapeutics, Inc, MaxCyte, Inc, Medigene AG, MEDIPOST CO. and Mesoblast Limited, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cell Therapy and Tissue Engineering companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell Therapy and Tissue Engineering Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cell Therapy and Tissue Engineering Market Segment Percentages, by Type, 2021 (%)
- Cell Therapy
- Tissue Engineering
Global Cell Therapy and Tissue Engineering Market Segment Percentages, by Application, 2021 (%)
- Cell Defects
- Genetic Diseases
- Neurodegenerative Diseases
- Tissue Malignancies
- Others
Global Cell Therapy and Tissue Engineering Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Cell Therapy and Tissue Engineering revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cell Therapy and Tissue Engineering revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Betalin Therapeutics
- BioCardia, Inc
- BioReliance Corporation
- Biosolution Co.
- Brainstorm Cell Therapeutics, Inc
- MaxCyte, Inc
- Medigene AG
- MEDIPOST CO.
- Mesoblast Limited
- Miromatrix Medical, Inc.
- MolMed S.p.A
- Mustang Bio, Inc
- NantKwest, Inc.
- Neuralstem, Inc
- NexImmune, Inc.
- Nohla Therapeutics, Inc
- ReNeuron Group plc
- Richter-Helm BioLogics GmbH & Co. KG
- RoosterBio, Inc
- RoslinCT
- Rubius Therapeutics, Inc.
- Sangamo Therapeutics, Inc
- Voyager Therapeutics, Inc
- Waisman Biomanufacturing
- WindMIL Therapeutics, Inc.
- Wuxi App Tec, Inc.
- ReNeuron Group plc
- Richter-Helm BioLogics GmbH & Co. KG
- RoosterBio, Inc
- RoslinCT
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Cell Therapy and Tissue Engineering Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell Therapy and Tissue Engineering Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CELL THERAPY AND TISSUE ENGINEERING OVERALL MARKET SIZE
2.1 Global Cell Therapy and Tissue Engineering Market Size: 2021 VS 2028
2.2 Global Cell Therapy and Tissue Engineering Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Cell Therapy and Tissue Engineering Players in Global Market
3.2 Top Global Cell Therapy and Tissue Engineering Companies Ranked by Revenue
3.3 Global Cell Therapy and Tissue Engineering Revenue by Companies
3.4 Top 3 and Top 5 Cell Therapy and Tissue Engineering Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cell Therapy and Tissue Engineering Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell Therapy and Tissue Engineering Players in Global Market
3.6.1 List of Global Tier 1 Cell Therapy and Tissue Engineering Companies
3.6.2 List of Global Tier 2 and Tier 3 Cell Therapy and Tissue Engineering Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Cell Therapy and Tissue Engineering Market Size Markets, 2021 & 2028
4.1.2 Cell Therapy
4.1.3 Tissue Engineering
4.2 By Type - Global Cell Therapy and Tissue Engineering Revenue & Forecasts
4.2.1 By Type - Global Cell Therapy and Tissue Engineering Revenue, 2017-2022
4.2.2 By Type - Global Cell Therapy and Tissue Engineering Revenue, 2023-2028
4.2.3 By Type - Global Cell Therapy and Tissue Engineering Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Cell Therapy and Tissue Engineering Market Size, 2021 & 2028
5.1.2 Cell Defects
5.1.3 Genetic Diseases
5.1.4 Neurodegenerative Diseases
5.1.5 Tissue Malignancies
5.1.6 Others
5.2 By Application - Global Cell Therapy and Tissue Engineering Revenue & Forecasts
5.2.1 By Application - Global Cell Therapy and Tissue Engineering Revenue, 2017-2022
5.2.2 By Application - Global Cell Therapy and Tissue Engineering Revenue, 2023-2028
5.2.3 By Application - Global Cell Therapy and Tissue Engineering Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Cell Therapy and Tissue Engineering Market Size, 2021 & 2028
6.2 By Region - Global Cell Therapy and Tissue Engineering Revenue & Forecasts
6.2.1 By Region - Global Cell Therapy and Tissue Engineering Revenue, 2017-2022
6.2.2 By Region - Global Cell Therapy and Tissue Engineering Revenue, 2023-2028
6.2.3 By Region - Global Cell Therapy and Tissue Engineering Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Cell Therapy and Tissue Engineering Revenue, 2017-2028
6.3.2 US Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.3.3 Canada Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.3.4 Mexico Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Cell Therapy and Tissue Engineering Revenue, 2017-2028
6.4.2 Germany Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.4.3 France Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.4.4 U.K. Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.4.5 Italy Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.4.6 Russia Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.4.7 Nordic Countries Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.4.8 Benelux Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Cell Therapy and Tissue Engineering Revenue, 2017-2028
6.5.2 China Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.5.3 Japan Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.5.4 South Korea Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.5.5 Southeast Asia Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.5.6 India Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Cell Therapy and Tissue Engineering Revenue, 2017-2028
6.6.2 Brazil Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.6.3 Argentina Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cell Therapy and Tissue Engineering Revenue, 2017-2028
6.7.2 Turkey Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.7.3 Israel Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.7.4 Saudi Arabia Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.7.5 UAE Cell Therapy and Tissue Engineering Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Betalin Therapeutics
7.1.1 Betalin Therapeutics Corporate Summary
7.1.2 Betalin Therapeutics Business Overview
7.1.3 Betalin Therapeutics Cell Therapy and Tissue Engineering Major Product Offerings
7.1.4 Betalin Therapeutics Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.1.5 Betalin Therapeutics Key News
7.2 BioCardia, Inc
7.2.1 BioCardia, Inc Corporate Summary
7.2.2 BioCardia, Inc Business Overview
7.2.3 BioCardia, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.2.4 BioCardia, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.2.5 BioCardia, Inc Key News
7.3 BioReliance Corporation
7.3.1 BioReliance Corporation Corporate Summary
7.3.2 BioReliance Corporation Business Overview
7.3.3 BioReliance Corporation Cell Therapy and Tissue Engineering Major Product Offerings
7.3.4 BioReliance Corporation Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.3.5 BioReliance Corporation Key News
7.4 Biosolution Co.
7.4.1 Biosolution Co. Corporate Summary
7.4.2 Biosolution Co. Business Overview
7.4.3 Biosolution Co. Cell Therapy and Tissue Engineering Major Product Offerings
7.4.4 Biosolution Co. Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.4.5 Biosolution Co. Key News
7.5 Brainstorm Cell Therapeutics, Inc
7.5.1 Brainstorm Cell Therapeutics, Inc Corporate Summary
7.5.2 Brainstorm Cell Therapeutics, Inc Business Overview
7.5.3 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.5.4 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.5.5 Brainstorm Cell Therapeutics, Inc Key News
7.6 MaxCyte, Inc
7.6.1 MaxCyte, Inc Corporate Summary
7.6.2 MaxCyte, Inc Business Overview
7.6.3 MaxCyte, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.6.4 MaxCyte, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.6.5 MaxCyte, Inc Key News
7.7 Medigene AG
7.7.1 Medigene AG Corporate Summary
7.7.2 Medigene AG Business Overview
7.7.3 Medigene AG Cell Therapy and Tissue Engineering Major Product Offerings
7.7.4 Medigene AG Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.7.5 Medigene AG Key News
7.8 MEDIPOST CO.
7.8.1 MEDIPOST CO. Corporate Summary
7.8.2 MEDIPOST CO. Business Overview
7.8.3 MEDIPOST CO. Cell Therapy and Tissue Engineering Major Product Offerings
7.8.4 MEDIPOST CO. Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.8.5 MEDIPOST CO. Key News
7.9 Mesoblast Limited
7.9.1 Mesoblast Limited Corporate Summary
7.9.2 Mesoblast Limited Business Overview
7.9.3 Mesoblast Limited Cell Therapy and Tissue Engineering Major Product Offerings
7.9.4 Mesoblast Limited Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.9.5 Mesoblast Limited Key News
7.10 Miromatrix Medical, Inc.
7.10.1 Miromatrix Medical, Inc. Corporate Summary
7.10.2 Miromatrix Medical, Inc. Business Overview
7.10.3 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Major Product Offerings
7.10.4 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.10.5 Miromatrix Medical, Inc. Key News
7.11 MolMed S.p.A
7.11.1 MolMed S.p.A Corporate Summary
7.11.2 MolMed S.p.A Business Overview
7.11.3 MolMed S.p.A Cell Therapy and Tissue Engineering Major Product Offerings
7.11.4 MolMed S.p.A Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.11.5 MolMed S.p.A Key News
7.12 Mustang Bio, Inc
7.12.1 Mustang Bio, Inc Corporate Summary
7.12.2 Mustang Bio, Inc Business Overview
7.12.3 Mustang Bio, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.12.4 Mustang Bio, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.12.5 Mustang Bio, Inc Key News
7.13 NantKwest, Inc.
7.13.1 NantKwest, Inc. Corporate Summary
7.13.2 NantKwest, Inc. Business Overview
7.13.3 NantKwest, Inc. Cell Therapy and Tissue Engineering Major Product Offerings
7.13.4 NantKwest, Inc. Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.13.5 NantKwest, Inc. Key News
7.14 Neuralstem, Inc
7.14.1 Neuralstem, Inc Corporate Summary
7.14.2 Neuralstem, Inc Business Overview
7.14.3 Neuralstem, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.14.4 Neuralstem, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.14.5 Neuralstem, Inc Key News
7.15 NexImmune, Inc.
7.15.1 NexImmune, Inc. Corporate Summary
7.15.2 NexImmune, Inc. Business Overview
7.15.3 NexImmune, Inc. Cell Therapy and Tissue Engineering Major Product Offerings
7.15.4 NexImmune, Inc. Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.15.5 NexImmune, Inc. Key News
7.16 Nohla Therapeutics, Inc
7.16.1 Nohla Therapeutics, Inc Corporate Summary
7.16.2 Nohla Therapeutics, Inc Business Overview
7.16.3 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.16.4 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.16.5 Nohla Therapeutics, Inc Key News
7.17 ReNeuron Group plc
7.17.1 ReNeuron Group plc Corporate Summary
7.17.2 ReNeuron Group plc Business Overview
7.17.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Major Product Offerings
7.17.4 ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.17.5 ReNeuron Group plc Key News
7.18 Richter-Helm BioLogics GmbH & Co. KG
7.18.1 Richter-Helm BioLogics GmbH & Co. KG Corporate Summary
7.18.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview
7.18.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Major Product Offerings
7.18.4 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.18.5 Richter-Helm BioLogics GmbH & Co. KG Key News
7.19 RoosterBio, Inc
7.19.1 RoosterBio, Inc Corporate Summary
7.19.2 RoosterBio, Inc Business Overview
7.19.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.19.4 RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.19.5 RoosterBio, Inc Key News
7.20 RoslinCT
7.20.1 RoslinCT Corporate Summary
7.20.2 RoslinCT Business Overview
7.20.3 RoslinCT Cell Therapy and Tissue Engineering Major Product Offerings
7.20.4 RoslinCT Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.20.5 RoslinCT Key News
7.21 Rubius Therapeutics, Inc.
7.21.1 Rubius Therapeutics, Inc. Corporate Summary
7.21.2 Rubius Therapeutics, Inc. Business Overview
7.21.3 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Major Product Offerings
7.21.4 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.21.5 Rubius Therapeutics, Inc. Key News
7.22 Sangamo Therapeutics, Inc
7.22.1 Sangamo Therapeutics, Inc Corporate Summary
7.22.2 Sangamo Therapeutics, Inc Business Overview
7.22.3 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.22.4 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.22.5 Sangamo Therapeutics, Inc Key News
7.23 Voyager Therapeutics, Inc
7.23.1 Voyager Therapeutics, Inc Corporate Summary
7.23.2 Voyager Therapeutics, Inc Business Overview
7.23.3 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.23.4 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.23.5 Voyager Therapeutics, Inc Key News
7.24 Waisman Biomanufacturing
7.24.1 Waisman Biomanufacturing Corporate Summary
7.24.2 Waisman Biomanufacturing Business Overview
7.24.3 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Major Product Offerings
7.24.4 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.24.5 Waisman Biomanufacturing Key News
7.25 WindMIL Therapeutics, Inc.
7.25.1 WindMIL Therapeutics, Inc. Corporate Summary
7.25.2 WindMIL Therapeutics, Inc. Business Overview
7.25.3 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Major Product Offerings
7.25.4 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.25.5 WindMIL Therapeutics, Inc. Key News
7.26 Wuxi App Tec, Inc.
7.26.1 Wuxi App Tec, Inc. Corporate Summary
7.26.2 Wuxi App Tec, Inc. Business Overview
7.26.3 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Major Product Offerings
7.26.4 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.26.5 Wuxi App Tec, Inc. Key News
7.27 ReNeuron Group plc
7.27.1 ReNeuron Group plc Corporate Summary
7.27.2 ReNeuron Group plc Business Overview
7.27.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Major Product Offerings
7.27.4 ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.27.5 ReNeuron Group plc Key News
7.28 Richter-Helm BioLogics GmbH & Co. KG
7.28.1 Richter-Helm BioLogics GmbH & Co. KG Corporate Summary
7.28.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview
7.28.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Major Product Offerings
7.28.4 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.28.5 Richter-Helm BioLogics GmbH & Co. KG Key News
7.29 RoosterBio, Inc
7.29.1 RoosterBio, Inc Corporate Summary
7.29.2 RoosterBio, Inc Business Overview
7.29.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.29.4 RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.29.5 RoosterBio, Inc Key News
7.30 RoslinCT
7.30.1 RoslinCT Corporate Summary
7.30.2 RoslinCT Business Overview
7.30.3 RoslinCT Cell Therapy and Tissue Engineering Major Product Offerings
7.30.4 RoslinCT Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.30.5 RoslinCT Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Cell Therapy and Tissue Engineering Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell Therapy and Tissue Engineering Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CELL THERAPY AND TISSUE ENGINEERING OVERALL MARKET SIZE
2.1 Global Cell Therapy and Tissue Engineering Market Size: 2021 VS 2028
2.2 Global Cell Therapy and Tissue Engineering Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Cell Therapy and Tissue Engineering Players in Global Market
3.2 Top Global Cell Therapy and Tissue Engineering Companies Ranked by Revenue
3.3 Global Cell Therapy and Tissue Engineering Revenue by Companies
3.4 Top 3 and Top 5 Cell Therapy and Tissue Engineering Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cell Therapy and Tissue Engineering Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell Therapy and Tissue Engineering Players in Global Market
3.6.1 List of Global Tier 1 Cell Therapy and Tissue Engineering Companies
3.6.2 List of Global Tier 2 and Tier 3 Cell Therapy and Tissue Engineering Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Cell Therapy and Tissue Engineering Market Size Markets, 2021 & 2028
4.1.2 Cell Therapy
4.1.3 Tissue Engineering
4.2 By Type - Global Cell Therapy and Tissue Engineering Revenue & Forecasts
4.2.1 By Type - Global Cell Therapy and Tissue Engineering Revenue, 2017-2022
4.2.2 By Type - Global Cell Therapy and Tissue Engineering Revenue, 2023-2028
4.2.3 By Type - Global Cell Therapy and Tissue Engineering Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Cell Therapy and Tissue Engineering Market Size, 2021 & 2028
5.1.2 Cell Defects
5.1.3 Genetic Diseases
5.1.4 Neurodegenerative Diseases
5.1.5 Tissue Malignancies
5.1.6 Others
5.2 By Application - Global Cell Therapy and Tissue Engineering Revenue & Forecasts
5.2.1 By Application - Global Cell Therapy and Tissue Engineering Revenue, 2017-2022
5.2.2 By Application - Global Cell Therapy and Tissue Engineering Revenue, 2023-2028
5.2.3 By Application - Global Cell Therapy and Tissue Engineering Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Cell Therapy and Tissue Engineering Market Size, 2021 & 2028
6.2 By Region - Global Cell Therapy and Tissue Engineering Revenue & Forecasts
6.2.1 By Region - Global Cell Therapy and Tissue Engineering Revenue, 2017-2022
6.2.2 By Region - Global Cell Therapy and Tissue Engineering Revenue, 2023-2028
6.2.3 By Region - Global Cell Therapy and Tissue Engineering Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Cell Therapy and Tissue Engineering Revenue, 2017-2028
6.3.2 US Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.3.3 Canada Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.3.4 Mexico Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Cell Therapy and Tissue Engineering Revenue, 2017-2028
6.4.2 Germany Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.4.3 France Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.4.4 U.K. Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.4.5 Italy Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.4.6 Russia Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.4.7 Nordic Countries Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.4.8 Benelux Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Cell Therapy and Tissue Engineering Revenue, 2017-2028
6.5.2 China Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.5.3 Japan Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.5.4 South Korea Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.5.5 Southeast Asia Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.5.6 India Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Cell Therapy and Tissue Engineering Revenue, 2017-2028
6.6.2 Brazil Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.6.3 Argentina Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cell Therapy and Tissue Engineering Revenue, 2017-2028
6.7.2 Turkey Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.7.3 Israel Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.7.4 Saudi Arabia Cell Therapy and Tissue Engineering Market Size, 2017-2028
6.7.5 UAE Cell Therapy and Tissue Engineering Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Betalin Therapeutics
7.1.1 Betalin Therapeutics Corporate Summary
7.1.2 Betalin Therapeutics Business Overview
7.1.3 Betalin Therapeutics Cell Therapy and Tissue Engineering Major Product Offerings
7.1.4 Betalin Therapeutics Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.1.5 Betalin Therapeutics Key News
7.2 BioCardia, Inc
7.2.1 BioCardia, Inc Corporate Summary
7.2.2 BioCardia, Inc Business Overview
7.2.3 BioCardia, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.2.4 BioCardia, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.2.5 BioCardia, Inc Key News
7.3 BioReliance Corporation
7.3.1 BioReliance Corporation Corporate Summary
7.3.2 BioReliance Corporation Business Overview
7.3.3 BioReliance Corporation Cell Therapy and Tissue Engineering Major Product Offerings
7.3.4 BioReliance Corporation Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.3.5 BioReliance Corporation Key News
7.4 Biosolution Co.
7.4.1 Biosolution Co. Corporate Summary
7.4.2 Biosolution Co. Business Overview
7.4.3 Biosolution Co. Cell Therapy and Tissue Engineering Major Product Offerings
7.4.4 Biosolution Co. Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.4.5 Biosolution Co. Key News
7.5 Brainstorm Cell Therapeutics, Inc
7.5.1 Brainstorm Cell Therapeutics, Inc Corporate Summary
7.5.2 Brainstorm Cell Therapeutics, Inc Business Overview
7.5.3 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.5.4 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.5.5 Brainstorm Cell Therapeutics, Inc Key News
7.6 MaxCyte, Inc
7.6.1 MaxCyte, Inc Corporate Summary
7.6.2 MaxCyte, Inc Business Overview
7.6.3 MaxCyte, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.6.4 MaxCyte, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.6.5 MaxCyte, Inc Key News
7.7 Medigene AG
7.7.1 Medigene AG Corporate Summary
7.7.2 Medigene AG Business Overview
7.7.3 Medigene AG Cell Therapy and Tissue Engineering Major Product Offerings
7.7.4 Medigene AG Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.7.5 Medigene AG Key News
7.8 MEDIPOST CO.
7.8.1 MEDIPOST CO. Corporate Summary
7.8.2 MEDIPOST CO. Business Overview
7.8.3 MEDIPOST CO. Cell Therapy and Tissue Engineering Major Product Offerings
7.8.4 MEDIPOST CO. Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.8.5 MEDIPOST CO. Key News
7.9 Mesoblast Limited
7.9.1 Mesoblast Limited Corporate Summary
7.9.2 Mesoblast Limited Business Overview
7.9.3 Mesoblast Limited Cell Therapy and Tissue Engineering Major Product Offerings
7.9.4 Mesoblast Limited Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.9.5 Mesoblast Limited Key News
7.10 Miromatrix Medical, Inc.
7.10.1 Miromatrix Medical, Inc. Corporate Summary
7.10.2 Miromatrix Medical, Inc. Business Overview
7.10.3 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Major Product Offerings
7.10.4 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.10.5 Miromatrix Medical, Inc. Key News
7.11 MolMed S.p.A
7.11.1 MolMed S.p.A Corporate Summary
7.11.2 MolMed S.p.A Business Overview
7.11.3 MolMed S.p.A Cell Therapy and Tissue Engineering Major Product Offerings
7.11.4 MolMed S.p.A Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.11.5 MolMed S.p.A Key News
7.12 Mustang Bio, Inc
7.12.1 Mustang Bio, Inc Corporate Summary
7.12.2 Mustang Bio, Inc Business Overview
7.12.3 Mustang Bio, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.12.4 Mustang Bio, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.12.5 Mustang Bio, Inc Key News
7.13 NantKwest, Inc.
7.13.1 NantKwest, Inc. Corporate Summary
7.13.2 NantKwest, Inc. Business Overview
7.13.3 NantKwest, Inc. Cell Therapy and Tissue Engineering Major Product Offerings
7.13.4 NantKwest, Inc. Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.13.5 NantKwest, Inc. Key News
7.14 Neuralstem, Inc
7.14.1 Neuralstem, Inc Corporate Summary
7.14.2 Neuralstem, Inc Business Overview
7.14.3 Neuralstem, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.14.4 Neuralstem, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.14.5 Neuralstem, Inc Key News
7.15 NexImmune, Inc.
7.15.1 NexImmune, Inc. Corporate Summary
7.15.2 NexImmune, Inc. Business Overview
7.15.3 NexImmune, Inc. Cell Therapy and Tissue Engineering Major Product Offerings
7.15.4 NexImmune, Inc. Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.15.5 NexImmune, Inc. Key News
7.16 Nohla Therapeutics, Inc
7.16.1 Nohla Therapeutics, Inc Corporate Summary
7.16.2 Nohla Therapeutics, Inc Business Overview
7.16.3 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.16.4 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.16.5 Nohla Therapeutics, Inc Key News
7.17 ReNeuron Group plc
7.17.1 ReNeuron Group plc Corporate Summary
7.17.2 ReNeuron Group plc Business Overview
7.17.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Major Product Offerings
7.17.4 ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.17.5 ReNeuron Group plc Key News
7.18 Richter-Helm BioLogics GmbH & Co. KG
7.18.1 Richter-Helm BioLogics GmbH & Co. KG Corporate Summary
7.18.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview
7.18.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Major Product Offerings
7.18.4 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.18.5 Richter-Helm BioLogics GmbH & Co. KG Key News
7.19 RoosterBio, Inc
7.19.1 RoosterBio, Inc Corporate Summary
7.19.2 RoosterBio, Inc Business Overview
7.19.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.19.4 RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.19.5 RoosterBio, Inc Key News
7.20 RoslinCT
7.20.1 RoslinCT Corporate Summary
7.20.2 RoslinCT Business Overview
7.20.3 RoslinCT Cell Therapy and Tissue Engineering Major Product Offerings
7.20.4 RoslinCT Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.20.5 RoslinCT Key News
7.21 Rubius Therapeutics, Inc.
7.21.1 Rubius Therapeutics, Inc. Corporate Summary
7.21.2 Rubius Therapeutics, Inc. Business Overview
7.21.3 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Major Product Offerings
7.21.4 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.21.5 Rubius Therapeutics, Inc. Key News
7.22 Sangamo Therapeutics, Inc
7.22.1 Sangamo Therapeutics, Inc Corporate Summary
7.22.2 Sangamo Therapeutics, Inc Business Overview
7.22.3 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.22.4 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.22.5 Sangamo Therapeutics, Inc Key News
7.23 Voyager Therapeutics, Inc
7.23.1 Voyager Therapeutics, Inc Corporate Summary
7.23.2 Voyager Therapeutics, Inc Business Overview
7.23.3 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.23.4 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.23.5 Voyager Therapeutics, Inc Key News
7.24 Waisman Biomanufacturing
7.24.1 Waisman Biomanufacturing Corporate Summary
7.24.2 Waisman Biomanufacturing Business Overview
7.24.3 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Major Product Offerings
7.24.4 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.24.5 Waisman Biomanufacturing Key News
7.25 WindMIL Therapeutics, Inc.
7.25.1 WindMIL Therapeutics, Inc. Corporate Summary
7.25.2 WindMIL Therapeutics, Inc. Business Overview
7.25.3 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Major Product Offerings
7.25.4 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.25.5 WindMIL Therapeutics, Inc. Key News
7.26 Wuxi App Tec, Inc.
7.26.1 Wuxi App Tec, Inc. Corporate Summary
7.26.2 Wuxi App Tec, Inc. Business Overview
7.26.3 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Major Product Offerings
7.26.4 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.26.5 Wuxi App Tec, Inc. Key News
7.27 ReNeuron Group plc
7.27.1 ReNeuron Group plc Corporate Summary
7.27.2 ReNeuron Group plc Business Overview
7.27.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Major Product Offerings
7.27.4 ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.27.5 ReNeuron Group plc Key News
7.28 Richter-Helm BioLogics GmbH & Co. KG
7.28.1 Richter-Helm BioLogics GmbH & Co. KG Corporate Summary
7.28.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview
7.28.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Major Product Offerings
7.28.4 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.28.5 Richter-Helm BioLogics GmbH & Co. KG Key News
7.29 RoosterBio, Inc
7.29.1 RoosterBio, Inc Corporate Summary
7.29.2 RoosterBio, Inc Business Overview
7.29.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.29.4 RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.29.5 RoosterBio, Inc Key News
7.30 RoslinCT
7.30.1 RoslinCT Corporate Summary
7.30.2 RoslinCT Business Overview
7.30.3 RoslinCT Cell Therapy and Tissue Engineering Major Product Offerings
7.30.4 RoslinCT Cell Therapy and Tissue Engineering Revenue in Global Market (2017-2022)
7.30.5 RoslinCT Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Cell Therapy and Tissue Engineering Market Opportunities & Trends in Global Market
Table 2. Cell Therapy and Tissue Engineering Market Drivers in Global Market
Table 3. Cell Therapy and Tissue Engineering Market Restraints in Global Market
Table 4. Key Players of Cell Therapy and Tissue Engineering in Global Market
Table 5. Top Cell Therapy and Tissue Engineering Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cell Therapy and Tissue Engineering Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cell Therapy and Tissue Engineering Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cell Therapy and Tissue Engineering Product Type
Table 9. List of Global Tier 1 Cell Therapy and Tissue Engineering Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cell Therapy and Tissue Engineering Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cell Therapy and Tissue Engineering Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cell Therapy and Tissue Engineering Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cell Therapy and Tissue Engineering Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cell Therapy and Tissue Engineering Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cell Therapy and Tissue Engineering Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cell Therapy and Tissue Engineering Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2023-2028
Table 30. Betalin Therapeutics Corporate Summary
Table 31. Betalin Therapeutics Cell Therapy and Tissue Engineering Product Offerings
Table 32. Betalin Therapeutics Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 33. BioCardia, Inc Corporate Summary
Table 34. BioCardia, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 35. BioCardia, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 36. BioReliance Corporation Corporate Summary
Table 37. BioReliance Corporation Cell Therapy and Tissue Engineering Product Offerings
Table 38. BioReliance Corporation Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 39. Biosolution Co. Corporate Summary
Table 40. Biosolution Co. Cell Therapy and Tissue Engineering Product Offerings
Table 41. Biosolution Co. Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 42. Brainstorm Cell Therapeutics, Inc Corporate Summary
Table 43. Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 44. Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 45. MaxCyte, Inc Corporate Summary
Table 46. MaxCyte, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 47. MaxCyte, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 48. Medigene AG Corporate Summary
Table 49. Medigene AG Cell Therapy and Tissue Engineering Product Offerings
Table 50. Medigene AG Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 51. MEDIPOST CO. Corporate Summary
Table 52. MEDIPOST CO. Cell Therapy and Tissue Engineering Product Offerings
Table 53. MEDIPOST CO. Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 54. Mesoblast Limited Corporate Summary
Table 55. Mesoblast Limited Cell Therapy and Tissue Engineering Product Offerings
Table 56. Mesoblast Limited Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 57. Miromatrix Medical, Inc. Corporate Summary
Table 58. Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Product Offerings
Table 59. Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 60. MolMed S.p.A Corporate Summary
Table 61. MolMed S.p.A Cell Therapy and Tissue Engineering Product Offerings
Table 62. MolMed S.p.A Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 63. Mustang Bio, Inc Corporate Summary
Table 64. Mustang Bio, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 65. Mustang Bio, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 66. NantKwest, Inc. Corporate Summary
Table 67. NantKwest, Inc. Cell Therapy and Tissue Engineering Product Offerings
Table 68. NantKwest, Inc. Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 69. Neuralstem, Inc Corporate Summary
Table 70. Neuralstem, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 71. Neuralstem, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 72. NexImmune, Inc. Corporate Summary
Table 73. NexImmune, Inc. Cell Therapy and Tissue Engineering Product Offerings
Table 74. NexImmune, Inc. Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 75. Nohla Therapeutics, Inc Corporate Summary
Table 76. Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 77. Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 78. ReNeuron Group plc Corporate Summary
Table 79. ReNeuron Group plc Cell Therapy and Tissue Engineering Product Offerings
Table 80. ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 81. Richter-Helm BioLogics GmbH & Co. KG Corporate Summary
Table 82. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Product Offerings
Table 83. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 84. RoosterBio, Inc Corporate Summary
Table 85. RoosterBio, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 86. RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 87. RoslinCT Corporate Summary
Table 88. RoslinCT Cell Therapy and Tissue Engineering Product Offerings
Table 89. RoslinCT Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 90. Rubius Therapeutics, Inc. Corporate Summary
Table 91. Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Product Offerings
Table 92. Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 93. Sangamo Therapeutics, Inc Corporate Summary
Table 94. Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 95. Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 96. Voyager Therapeutics, Inc Corporate Summary
Table 97. Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 98. Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 99. Waisman Biomanufacturing Corporate Summary
Table 100. Waisman Biomanufacturing Cell Therapy and Tissue Engineering Product Offerings
Table 101. Waisman Biomanufacturing Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 102. WindMIL Therapeutics, Inc. Corporate Summary
Table 103. WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Product Offerings
Table 104. WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 105. Wuxi App Tec, Inc. Corporate Summary
Table 106. Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Product Offerings
Table 107. Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 108. ReNeuron Group plc Corporate Summary
Table 109. ReNeuron Group plc Cell Therapy and Tissue Engineering Product Offerings
Table 110. ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 111. Richter-Helm BioLogics GmbH & Co. KG Corporate Summary
Table 112. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Product Offerings
Table 113. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 114. RoosterBio, Inc Corporate Summary
Table 115. RoosterBio, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 116. RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 117. RoslinCT Corporate Summary
Table 118. RoslinCT Cell Therapy and Tissue Engineering Product Offerings
Table 119. RoslinCT Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 1. Cell Therapy and Tissue Engineering Market Opportunities & Trends in Global Market
Table 2. Cell Therapy and Tissue Engineering Market Drivers in Global Market
Table 3. Cell Therapy and Tissue Engineering Market Restraints in Global Market
Table 4. Key Players of Cell Therapy and Tissue Engineering in Global Market
Table 5. Top Cell Therapy and Tissue Engineering Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cell Therapy and Tissue Engineering Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cell Therapy and Tissue Engineering Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cell Therapy and Tissue Engineering Product Type
Table 9. List of Global Tier 1 Cell Therapy and Tissue Engineering Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cell Therapy and Tissue Engineering Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cell Therapy and Tissue Engineering Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cell Therapy and Tissue Engineering Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cell Therapy and Tissue Engineering Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cell Therapy and Tissue Engineering Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cell Therapy and Tissue Engineering Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cell Therapy and Tissue Engineering Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2023-2028
Table 30. Betalin Therapeutics Corporate Summary
Table 31. Betalin Therapeutics Cell Therapy and Tissue Engineering Product Offerings
Table 32. Betalin Therapeutics Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 33. BioCardia, Inc Corporate Summary
Table 34. BioCardia, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 35. BioCardia, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 36. BioReliance Corporation Corporate Summary
Table 37. BioReliance Corporation Cell Therapy and Tissue Engineering Product Offerings
Table 38. BioReliance Corporation Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 39. Biosolution Co. Corporate Summary
Table 40. Biosolution Co. Cell Therapy and Tissue Engineering Product Offerings
Table 41. Biosolution Co. Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 42. Brainstorm Cell Therapeutics, Inc Corporate Summary
Table 43. Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 44. Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 45. MaxCyte, Inc Corporate Summary
Table 46. MaxCyte, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 47. MaxCyte, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 48. Medigene AG Corporate Summary
Table 49. Medigene AG Cell Therapy and Tissue Engineering Product Offerings
Table 50. Medigene AG Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 51. MEDIPOST CO. Corporate Summary
Table 52. MEDIPOST CO. Cell Therapy and Tissue Engineering Product Offerings
Table 53. MEDIPOST CO. Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 54. Mesoblast Limited Corporate Summary
Table 55. Mesoblast Limited Cell Therapy and Tissue Engineering Product Offerings
Table 56. Mesoblast Limited Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 57. Miromatrix Medical, Inc. Corporate Summary
Table 58. Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Product Offerings
Table 59. Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 60. MolMed S.p.A Corporate Summary
Table 61. MolMed S.p.A Cell Therapy and Tissue Engineering Product Offerings
Table 62. MolMed S.p.A Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 63. Mustang Bio, Inc Corporate Summary
Table 64. Mustang Bio, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 65. Mustang Bio, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 66. NantKwest, Inc. Corporate Summary
Table 67. NantKwest, Inc. Cell Therapy and Tissue Engineering Product Offerings
Table 68. NantKwest, Inc. Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 69. Neuralstem, Inc Corporate Summary
Table 70. Neuralstem, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 71. Neuralstem, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 72. NexImmune, Inc. Corporate Summary
Table 73. NexImmune, Inc. Cell Therapy and Tissue Engineering Product Offerings
Table 74. NexImmune, Inc. Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 75. Nohla Therapeutics, Inc Corporate Summary
Table 76. Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 77. Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 78. ReNeuron Group plc Corporate Summary
Table 79. ReNeuron Group plc Cell Therapy and Tissue Engineering Product Offerings
Table 80. ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 81. Richter-Helm BioLogics GmbH & Co. KG Corporate Summary
Table 82. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Product Offerings
Table 83. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 84. RoosterBio, Inc Corporate Summary
Table 85. RoosterBio, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 86. RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 87. RoslinCT Corporate Summary
Table 88. RoslinCT Cell Therapy and Tissue Engineering Product Offerings
Table 89. RoslinCT Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 90. Rubius Therapeutics, Inc. Corporate Summary
Table 91. Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Product Offerings
Table 92. Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 93. Sangamo Therapeutics, Inc Corporate Summary
Table 94. Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 95. Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 96. Voyager Therapeutics, Inc Corporate Summary
Table 97. Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 98. Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 99. Waisman Biomanufacturing Corporate Summary
Table 100. Waisman Biomanufacturing Cell Therapy and Tissue Engineering Product Offerings
Table 101. Waisman Biomanufacturing Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 102. WindMIL Therapeutics, Inc. Corporate Summary
Table 103. WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Product Offerings
Table 104. WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 105. Wuxi App Tec, Inc. Corporate Summary
Table 106. Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Product Offerings
Table 107. Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 108. ReNeuron Group plc Corporate Summary
Table 109. ReNeuron Group plc Cell Therapy and Tissue Engineering Product Offerings
Table 110. ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 111. Richter-Helm BioLogics GmbH & Co. KG Corporate Summary
Table 112. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Product Offerings
Table 113. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 114. RoosterBio, Inc Corporate Summary
Table 115. RoosterBio, Inc Cell Therapy and Tissue Engineering Product Offerings
Table 116. RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
Table 117. RoslinCT Corporate Summary
Table 118. RoslinCT Cell Therapy and Tissue Engineering Product Offerings
Table 119. RoslinCT Cell Therapy and Tissue Engineering Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Cell Therapy and Tissue Engineering Segment by Type in 2021
Figure 2. Cell Therapy and Tissue Engineering Segment by Application in 2021
Figure 3. Global Cell Therapy and Tissue Engineering Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cell Therapy and Tissue Engineering Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cell Therapy and Tissue Engineering Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cell Therapy and Tissue Engineering Revenue in 2021
Figure 8. By Type - Global Cell Therapy and Tissue Engineering Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cell Therapy and Tissue Engineering Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cell Therapy and Tissue Engineering Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cell Therapy and Tissue Engineering Revenue Market Share, 2017-2028
Figure 12. US Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cell Therapy and Tissue Engineering Revenue Market Share, 2017-2028
Figure 16. Germany Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 17. France Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cell Therapy and Tissue Engineering Revenue Market Share, 2017-2028
Figure 24. China Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 28. India Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cell Therapy and Tissue Engineering Revenue Market Share, 2017-2028
Figure 30. Brazil Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cell Therapy and Tissue Engineering Revenue Market Share, 2017-2028
Figure 33. Turkey Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 37. Betalin Therapeutics Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. BioCardia, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. BioReliance Corporation Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Biosolution Co. Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. MaxCyte, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Medigene AG Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. MEDIPOST CO. Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Mesoblast Limited Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. MolMed S.p.A Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Mustang Bio, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. NantKwest, Inc. Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Neuralstem, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. NexImmune, Inc. Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. RoslinCT Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 60. Waisman Biomanufacturing Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 61. WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 62. Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 63. ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 64. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 65. RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 66. RoslinCT Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Cell Therapy and Tissue Engineering Segment by Type in 2021
Figure 2. Cell Therapy and Tissue Engineering Segment by Application in 2021
Figure 3. Global Cell Therapy and Tissue Engineering Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cell Therapy and Tissue Engineering Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cell Therapy and Tissue Engineering Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cell Therapy and Tissue Engineering Revenue in 2021
Figure 8. By Type - Global Cell Therapy and Tissue Engineering Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cell Therapy and Tissue Engineering Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cell Therapy and Tissue Engineering Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cell Therapy and Tissue Engineering Revenue Market Share, 2017-2028
Figure 12. US Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cell Therapy and Tissue Engineering Revenue Market Share, 2017-2028
Figure 16. Germany Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 17. France Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cell Therapy and Tissue Engineering Revenue Market Share, 2017-2028
Figure 24. China Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 28. India Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cell Therapy and Tissue Engineering Revenue Market Share, 2017-2028
Figure 30. Brazil Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cell Therapy and Tissue Engineering Revenue Market Share, 2017-2028
Figure 33. Turkey Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cell Therapy and Tissue Engineering Revenue, (US$, Mn), 2017-2028
Figure 37. Betalin Therapeutics Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. BioCardia, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. BioReliance Corporation Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Biosolution Co. Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. MaxCyte, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Medigene AG Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. MEDIPOST CO. Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Mesoblast Limited Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. MolMed S.p.A Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Mustang Bio, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. NantKwest, Inc. Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Neuralstem, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. NexImmune, Inc. Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. RoslinCT Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 60. Waisman Biomanufacturing Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 61. WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 62. Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 63. ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 64. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 65. RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 66. RoslinCT Cell Therapy and Tissue Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
